Laurus Labs · NSE: LAURUSLABS · BSE: 540222
Q2 FY22 results · Jul–Sep 2021
Laurus Labs reported revenue from operations of ₹1,203.48 crore (up 5.7% from Q2 FY21) and net profit of ₹203.95 crore (down 15.8% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,203.48 | 1,138.84 | +5.7% | 1,278.50 | −5.9% |
| Other income | 2.83 | 5.12 | −44.7% | 5.85 | −51.6% |
| Total income | 1,206.31 | 1,143.96 | +5.5% | 1,284.35 | −6.1% |
| Profit before tax | 262.59 | 314.31 | −16.5% | 316.05 | −16.9% |
| Net profit for the period | 203.95 | 242.27 | −15.8% | 241.61 | −15.6% |
| Attributable to shareholders of the company | 201.90 | — | — | 241.39 | −16.4% |
| EPS, basic (₹) | 3.76 | 4.53 | −17.0% | 4.50 | −16.4% |
| Net margin (%) | 16.9 | 21.3 | 18.9 |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,176.20 | 1,127.30 | +4.3% | 1,220.60 | −3.6% |
| Other income | 4.50 | 6.58 | −31.6% | 7.57 | −40.6% |
| Total income | 1,180.70 | 1,133.88 | +4.1% | 1,228.17 | −3.9% |
| Profit before tax | 258.39 | 312.49 | −17.3% | 290.10 | −10.9% |
| Net profit for the period | 197.63 | 237.59 | −16.8% | 222.08 | −11.0% |
| EPS, basic (₹) | 3.68 | 4.44 | −17.1% | 4.14 | −11.1% |
| Net margin (%) | 16.8 | 21.1 | 18.2 |
Consolidated
- Filed with BSE
- 28 Oct 2021, 20:06 IST
- Board meeting
- 28 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 Oct 2021, 20:06 IST
- Board meeting
- 28 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE